Sriskandarajah, P., De Haven Brandon, A., MacLeod, K., Carragher, N. O., Kirkin, V., Kaiser, M., & Whittaker, S. R. (2020). Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myeloma. BMC Cancer.
Citação norma ChicagoSriskandarajah, Priya, Alexis De Haven Brandon, Kenneth MacLeod, Neil O. Carragher, Vladimir Kirkin, Martin Kaiser, and Steven R. Whittaker. "Combined Targeting of MEK and the Glucocorticoid Receptor for the Treatment of RAS-mutant Multiple Myeloma." BMC Cancer 2020.
MLA citiranjeSriskandarajah, Priya, et al. "Combined Targeting of MEK and the Glucocorticoid Receptor for the Treatment of RAS-mutant Multiple Myeloma." BMC Cancer 2020.
Opozorilo: Ti citati niso vedno 100% točni.